ag Search Results


99
Kinematica ag polytron
Polytron, supplied by Kinematica ag, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polytron/product/Kinematica ag
Average 99 stars, based on 1 article reviews
polytron - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

98
Sartorius AG vivaspin 20 centrifugal concentrator
Vivaspin 20 Centrifugal Concentrator, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vivaspin 20 centrifugal concentrator/product/Sartorius AG
Average 98 stars, based on 1 article reviews
vivaspin 20 centrifugal concentrator - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

86
Zeochem AG si al
Si Al, supplied by Zeochem AG, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/si al/product/Zeochem AG
Average 86 stars, based on 1 article reviews
si al - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

86
MorphoSys ag igg1 b anthracis infection phase iii cat hgs r1450 gantenerumab amyloid β nd alzheimer
Igg1 B Anthracis Infection Phase Iii Cat Hgs R1450 Gantenerumab Amyloid β Nd Alzheimer, supplied by MorphoSys ag, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/igg1 b anthracis infection phase iii cat hgs r1450 gantenerumab amyloid β nd alzheimer/product/MorphoSys ag
Average 86 stars, based on 1 article reviews
igg1 b anthracis infection phase iii cat hgs r1450 gantenerumab amyloid β nd alzheimer - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

86
Epigenomics ag chip seq data
Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as <t>histone</t> <t>ChIP-seq</t> or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.
Chip Seq Data, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chip seq data/product/Epigenomics ag
Average 86 stars, based on 1 article reviews
chip seq data - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

99
Eppendorf AG safe lock tube
Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as <t>histone</t> <t>ChIP-seq</t> or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.
Safe Lock Tube, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/safe lock tube/product/Eppendorf AG
Average 99 stars, based on 1 article reviews
safe lock tube - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

96
Bio-Rad l x8 anion exchange resin
Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as <t>histone</t> <t>ChIP-seq</t> or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.
L X8 Anion Exchange Resin, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/l x8 anion exchange resin/product/Bio-Rad
Average 96 stars, based on 1 article reviews
l x8 anion exchange resin - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Bio-Rad bio rad ag 50w x8 cation exchange resin
Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as <t>histone</t> <t>ChIP-seq</t> or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.
Bio Rad Ag 50w X8 Cation Exchange Resin, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bio rad ag 50w x8 cation exchange resin/product/Bio-Rad
Average 96 stars, based on 1 article reviews
bio rad ag 50w x8 cation exchange resin - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
Eppendorf AG centrifuge
Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as <t>histone</t> <t>ChIP-seq</t> or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.
Centrifuge, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/centrifuge/product/Eppendorf AG
Average 95 stars, based on 1 article reviews
centrifuge - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

99
Eppendorf AG micromanipulation system femtojet
Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as <t>histone</t> <t>ChIP-seq</t> or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.
Micromanipulation System Femtojet, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/micromanipulation system femtojet/product/Eppendorf AG
Average 99 stars, based on 1 article reviews
micromanipulation system femtojet - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

96
Sartorius AG md8 aluminum stacks
Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as <t>histone</t> <t>ChIP-seq</t> or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.
Md8 Aluminum Stacks, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/md8 aluminum stacks/product/Sartorius AG
Average 96 stars, based on 1 article reviews
md8 aluminum stacks - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Sartorius AG centrifuge concentrators
Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as <t>histone</t> <t>ChIP-seq</t> or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.
Centrifuge Concentrators, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/centrifuge concentrators/product/Sartorius AG
Average 96 stars, based on 1 article reviews
centrifuge concentrators - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

Image Search Results


Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as histone ChIP-seq or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.

Journal: Bioinformatics

Article Title: Deep5hmC: predicting genome-wide 5-hydroxymethylcytosine landscape via a multimodal deep learning model

doi: 10.1093/bioinformatics/btae528

Figure Lengend Snippet: Overview of Deep5hmC. ( A ) The training set of Deep5hmC can be derived from matched 5hmC-seq and other epigenetic data such as histone ChIP-seq or DNase-seq/ATAC-seq from one condition. Specifically, the 5hmC-seq data can be collected from tissue-specific human tissues, which include bladder, brain, breast, heart, kidney, liver, lung, marrow, ovary (female), pancreas, placenta (female), prostate (male), colon (sigmoid), colon (transverse), skin, stomach, and testis (male). The matched tissue-specific epigenetic data, such as histone ChIP-seq data profiling histone modification and DNase-seq/ATAC-seq profiling chromatin accessibility, can be collected from public consortiums such as Roadmap Epigenomics and ENCODE. In this context, Deep5hmC aims to predict genome-wide 5hmC modification in a single condition. ( B ) The training set of Deep5hmC can also be derived from matched 5hmC-seq and ChIP-seq from a case–control study (e.g. Alzheimer’s disease (AD) versus healthy control) for predicting differentially hydroxymethylated regions (DhMRs). ( C ) Deep5hmC is a multimodal deep learning model to improve the prediction of tissue/cell type-specific genome-wide 5hmC modification by leveraging both DNA sequence and epigenetic features such as histone modification and chromatin accessibility. Deep5hmC consists of four modules, including Deep5hmC-binary, Deep5hmC-cont, Deep5hmC-gene, and Deep5hmC-diff. Specifically, Deep5hmC-binary takes the labeled 5hmC peaks and non-peaks as the training set to identify the 5hmC-enriched regions. Deep5hmC-cont takes the normalized read counts in 5hmC peaks and aims to predict the continuous 5hmC modification genome-wide. By leveraging Deep5hmC-cont, Deep5hmC-gene aggregates the predictions of Deep5hmC-cont in the gene bodies as the surrogate for the predicted gene expression. Different from Deep5hmC-binary, Deep5hmC-diff takes the labeled DhMRs/non-DhMRs in a case–control design of 5hmC-seq as the training set to predict genome-wide DhMRs and may discover de novo DhMRs. ( D ) Model architecture of Deep5hmC. Deep5hmC consists of both sequence modality and epigenetic modality consisting of their own convolutional neural networks (CNNs) to derive separate feature representations, which will be joined later via the multi-modal factorized bilinear (MFB) pooling fusion layer. The output of the MFB fusion layer will further connect to fully connected layers and the output layer afterward.

Article Snippet: For “Human Tissues,” we carefully select aligned bed files of ChIP-seq data from Roadmap Epigenomics by ensuring a match between ChIP-seq data and 5hmC-seq data based on tissue type.

Techniques: Derivative Assay, ChIP-sequencing, Modification, Genome Wide, Control, Sequencing, Labeling, Expressing

Distribution pattern of histone modification around 5hmC peaks. EB 5hmC peaks are collected from “Forebrain Organoid” 5hmC-seq data and ChIP-seq data in “Brain Angular Gyrus” from seven histone marks are collected from Roadmap Epigenomics. Histone features are obtained and averaged in the neighborhood of all 5hmC peaks for the positive and negative sets, respectively. Specifically, histone features are created by segmenting an extended genomic region of 10 kb both upstream and downstream of each 5hmC peak into 41 1 kb windows with a sliding size of 500 bp and counting reads for each 1 kb windows. For each histone mark, the Kolmogorov–Smirnov test is performed to test the distribution difference of histone features between positive and negative 5hmC peaks and the P -value is reported.

Journal: Bioinformatics

Article Title: Deep5hmC: predicting genome-wide 5-hydroxymethylcytosine landscape via a multimodal deep learning model

doi: 10.1093/bioinformatics/btae528

Figure Lengend Snippet: Distribution pattern of histone modification around 5hmC peaks. EB 5hmC peaks are collected from “Forebrain Organoid” 5hmC-seq data and ChIP-seq data in “Brain Angular Gyrus” from seven histone marks are collected from Roadmap Epigenomics. Histone features are obtained and averaged in the neighborhood of all 5hmC peaks for the positive and negative sets, respectively. Specifically, histone features are created by segmenting an extended genomic region of 10 kb both upstream and downstream of each 5hmC peak into 41 1 kb windows with a sliding size of 500 bp and counting reads for each 1 kb windows. For each histone mark, the Kolmogorov–Smirnov test is performed to test the distribution difference of histone features between positive and negative 5hmC peaks and the P -value is reported.

Article Snippet: For “Human Tissues,” we carefully select aligned bed files of ChIP-seq data from Roadmap Epigenomics by ensuring a match between ChIP-seq data and 5hmC-seq data based on tissue type.

Techniques: Modification, ChIP-sequencing

Comparison of unimodal and multimodal Deep5hmC for predicting binary 5hmC modification sites. When using histone modification in the epigenetic modality, two unimodal models of Deep5hmC: Deep5hmC-Seq using only DNA sequence as the model input and Deep5hmC-His using only histone modification as the model input are compared to the default multimodal Deep5hmC-Seq+His using both DNA sequence and histone modification as the model input. 5hmC peaks from the EB stage “Forebrain Organoid” and two histone marks: H3K4me1 and H3K4me3 ChIP-seq data in all brain regions from Roadmap Epigenomics are used as the training set. ( A ) AUROC reported for three compared methods. ( B ) AUPRC reported three compared methods.

Journal: Bioinformatics

Article Title: Deep5hmC: predicting genome-wide 5-hydroxymethylcytosine landscape via a multimodal deep learning model

doi: 10.1093/bioinformatics/btae528

Figure Lengend Snippet: Comparison of unimodal and multimodal Deep5hmC for predicting binary 5hmC modification sites. When using histone modification in the epigenetic modality, two unimodal models of Deep5hmC: Deep5hmC-Seq using only DNA sequence as the model input and Deep5hmC-His using only histone modification as the model input are compared to the default multimodal Deep5hmC-Seq+His using both DNA sequence and histone modification as the model input. 5hmC peaks from the EB stage “Forebrain Organoid” and two histone marks: H3K4me1 and H3K4me3 ChIP-seq data in all brain regions from Roadmap Epigenomics are used as the training set. ( A ) AUROC reported for three compared methods. ( B ) AUPRC reported three compared methods.

Article Snippet: For “Human Tissues,” we carefully select aligned bed files of ChIP-seq data from Roadmap Epigenomics by ensuring a match between ChIP-seq data and 5hmC-seq data based on tissue type.

Techniques: Comparison, Modification, Sequencing, ChIP-sequencing